AI-Media to Showcase Real-Time Translation and Accessibility Workflows at ISE 2026 as Multilingual AV Demand Accelerates

AI-Media at ISE 2026 Join AI-Media at ISE 2026 and experience the future of AI-powered accessibility. BARCELONA, Spain, Jan. 29, 2026 (GLOBE NEWSWIRE) — AI-Media, a global leader in AI-powered subtitling and language solutions, will be at ISE 2026 to demonstrate how real-time translation, captioning, and audio description are becoming essential capabilities across professional AV environments […]

AI-Media to Showcase Real-Time Translation and Accessibility Workflows at ISE 2026 as Multilingual AV Demand Accelerates

AI-Media to Showcase Real-Time Translation and Accessibility Workflows at ISE 2026 as Multilingual AV Demand Accelerates Leave a reply AI-Media at ISE 2026 Join AI-Media at ISE 2026 and experience the future of AI-powered accessibility. BARCELONA, Spain, Jan. 29, 2026 (GLOBE NEWSWIRE) — AI-Media, a global leader in AI-powered subtitling and language solutions, will be at ISE 2026 to demonstrate how real-time translation, captioning, and audio description are becoming essential capabilities across professional AV environments – from live events and corporate communications to venues and public installations. As audiences become increasingly multilingual and expectations for inclusive communication continue to rise, AV teams are being challenged to deliver experiences that are accessible, understandable, and consistent across both in-room and remote viewing. At ISE 2026, AI-Media will share how its broadcast-grade AI technology is being applied to integrated AV workflows, enabling scalable, real-time language and accessibility support with low latency. At Booth 4L700, AI-Media will showcase LEXI Voice, an AI-driven solution delivering real-time voice translation into any language with natural-sounding output and minimal delay. Designed for live and broadcast environments, LEXI Voice supports event producers, content owners, and AV integrators looking to deliver multilingual communication without adding complexity to production workflows. Alongside LEXI Voice, AI-Media will also demonstrate LEXI Text, its real-time AI subtitling solution, and LEXI AD, which provides automated audio description to support inclusive viewing experiences. Together, the LEXI suite helps organisations deliver multilingual and accessible experiences across professional AV and broadcast environments – supporting a broader industry shift toward inclusive communication as a standard expectation, not an add-on. “Professional AV is moving quickly toward the same expectations broadcasters have operated under for years – reliability, low latency, and experiences that work across languages and accessibility needs,” said Mark Lovatt, VP Strategic Accounts and VP Sales – EMEA at AI-Media. “At

Fortrea Announces Date for Fourth Quarter and Full Year 2025 Financial Results and Conference Call

Fortrea Announces Date for Fourth Quarter and Full Year 2025 Financial Results and Conference Call Leave a reply DURHAM, N.C., Jan. 29, 2026 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that it will release its fourth quarter and full year 2025 financial results before the market opens on Thursday, February 26, 2026. Fortrea will host a conference call at 8:00 am ET that day to review its financial results and conduct a question-and-answer session. To participate in the earnings call, participants should register online at the Fortrea Investor Relations website. To avoid potential delays, please join at least 10 minutes prior to the start of the call. The conference call can also be accessed through the following earnings webcast link. A replay of the live conference call will be available shortly after the conclusion of the event and accessible on the events and presentations section of the Fortrea Investor Relations website. About Fortrea Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, biotechnology, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients. Fortrea provides phase I-IV clinical trial management, clinical pharmacology and consulting services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team working in about 100 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com and follow us on LinkedIn and X (formerly Twitter). Fortrea Contacts Tracy Krumme (Investors) – 984-385-6707, [email protected] Sue Zaranek (Media) – 919-943-5422, [email protected] Kate Dillon (Media)

Search

General News